Medical drug program updates
You can refer to the chart below to review changes and updates related to CarePartners of Connecticut's prior authorization and coverage program for medical drugs.
Updates to existing prior authorization programs | ||
Drug/MNG | Policy and additional information | Effective date
|
| In alignment with MassHealth criteria, we’ve updated the limitations section on the MNG to specify that Vyjuvek will not be used on the same target wounds as other topicals or gene therapies for a diagnosis of DEB, e.g., Filsuvez or Zevaskyn. | 12/1/2025 |